The Prevalence of Early Toxoplasmosis after Bone Marrow Transplantation Using PCR: A Study in Iranian Patients.

Abolghasemi, Sara; Khederzadeh, Sepideh; Salari, Sina; Mardani, Masoud; ArabMazar, Zahra; Ettefaghi, Mona; Kamrani, Ramiz; Ghorbi, Mahmoud Dehghani

Abolghasemi, Sara; Khederzadeh, Sepideh; Salari, Sina; Mardani, Masoud; ArabMazar, Zahra; Ettefaghi, Mona; Kamrani, Ramiz; Ghorbi, Mahmoud Dehghani.

Afiliação

Abolghasemi S; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Khederzadeh S; Department of Infectious Disease, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Salari S; Hematology and Medical Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mardani M; Infectious Diseases and Tropical Medicine Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
ArabMazar Z; Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Ettefaghi M; Department of Infectious Disease, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Kamrani R; Pulmonary Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Ghorbi MD; Shahid Beheshti University of Medical Sciences, Imam Hossein Hospital, Tehran, Iran.

Infect Disord Drug Targets ; 22(7): 62-66, 2022.

Article em En | MEDLINE | ID: mdl-35747960

Palavras-chave

IgM positive; PCR; Toxoplasmosis; bone marrow transplant; hematological disorders; immuno-comprimised organ

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Tipo de estudo: Prevalence_studies / Risk_factors_studies Idioma: En Revista: Infect Disord Drug Targets Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google